Schmidt, MK; Reincke, S; Broeks, A; Braaf, LM; Hogervorst, FBL; Tollenaar, R; Johnson, N; Fletcher, O; Peto, J; Tommiska, J; +8 more... Blomqvist, C; Nevanlinna, HA; Healey, CS; Dunning, AM; Pharoah, PDP; Easton, DF; Doork, T; Van't Veer, LJ; (2007) Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium. Cancer research, 67 (19). pp. 9584-9590. ISSN 0008-5472 DOI: https://doi.org/10.1158/0008-5472.CAN-07-0738 Full text not available from this repository.

Coombes, RC; Hall, E; Gibson, LJ; Paridaens, R; Jassem, J; Delozier, T; Jones, SE; Alvarez, I; Bertelli, G; Ortmann, O; +17 more... Coates, AS; Bajetta, E; Dodwell, D; Coleman, RE; Fallowfield, LJ; Mickiewicz, E; Andersen, J; Lønning, PE; Cocconi, G; Stewart, A; Stuart, N; Snowdon, CF; Carpentieri, M; Massimini, G; Bliss, JM; van de Velde, C; Intergroup Exemestane Study; (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. The New England journal of medicine, 350 (11). pp. 1081-92. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMoa040331

Donnellan, R; Kleinschmidt, I; Chetty, R; (2001) Cyclin E immunoexpression in breast ductal carcinoma: pathologic correlations and prognostic implications. Human pathology, 32 (1). pp. 89-94. ISSN 0046-8177 DOI: https://doi.org/10.1053/hupa.2001.21141 Full text not available from this repository.